FDA Approves Temporary Heart Pump for Patients with Shock
Last week, the U.S. Food and Drug Administration (FDA) approved the Impella heart pump to treat patients with severe heart failure (cardiogenic shock) after a heart attack or heart surgery. This is a major step and advancement in technology to help these very sick patients who need additional temporary support while the heart recovers its own function, or before they undergo further advanced treatments such as implantation of an artificial heart (Ventricular Assist Device [VAD]) or be considered for heart transplantation....